PMID- 17353181
OWN - NLM
STAT- MEDLINE
DCOM- 20081104
LR  - 20151119
IS  - 1080-2924 (Print)
IS  - 1080-2924 (Linking)
VI  - 13
IP  - 1
DP  - 2007
TI  - Blastoid mantle cell lymphoma occurring in a patient in complete remission of 
      chronic myelogenous leukemia.
PG  - 30-3
AB  - The development of a de novo lymphoma in patients affected by chronic myelogenous 
      leukemia (CML) is a rare event. The introduction of new molecular cytogenetic 
      techniques, such as fluorescence in situ hybridization (FISH), allows a correct 
      differential diagnosis between lymphoid blastic crisis and a blastoid variant of 
      mantle cell lymphoma (MCL), which shows an aggressive behavior and some molecular 
      characteristics detectable by cytogenetics and immunohistochemistry. We report a 
      case of a blastoid variant of MCL that developed in a patient with CML who 
      achieved complete cytogenetic and molecular response to imatinib mesylate 
      treatment.
FAU - Garzia, M
AU  - Garzia M
AD  - Dipartimento di Diagnostica Morfologica, Microbiologica, Molecolare e delle 
      Malattie del Sangue, Catholic University of Sacred Heart, Rome, Italy.
FAU - Sora, F
AU  - Sora F
FAU - Teofili, L
AU  - Teofili L
FAU - Di Mario, A
AU  - Di Mario A
FAU - Voso, M T
AU  - Voso MT
FAU - Rumi, C
AU  - Rumi C
FAU - La Rocca, L M
AU  - La Rocca LM
FAU - Sica, S
AU  - Sica S
FAU - Zini, G
AU  - Zini G
LA  - eng
PT  - Case Reports
PT  - Journal Article
PL  - United States
TA  - Lab Hematol
JT  - Laboratory hematology : official publication of the International Society for 
      Laboratory Hematology
JID - 9615688
RN  - 0 (Antineoplastic Agents)
RN  - 0 (Benzamides)
RN  - 0 (Piperazines)
RN  - 0 (Pyrimidines)
RN  - 8A1O1M485B (Imatinib Mesylate)
SB  - IM
MH  - Antineoplastic Agents/therapeutic use
MH  - Benzamides
MH  - Fatal Outcome
MH  - Humans
MH  - Imatinib Mesylate
MH  - Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*complications/drug therapy
MH  - Lymphoma, Mantle-Cell/*complications/*pathology
MH  - Male
MH  - Middle Aged
MH  - Piperazines/therapeutic use
MH  - Pyrimidines/therapeutic use
MH  - Remission Induction
EDAT- 2007/03/14 09:00
MHDA- 2008/11/05 09:00
CRDT- 2007/03/14 09:00
PHST- 2007/03/14 09:00 [pubmed]
PHST- 2008/11/05 09:00 [medline]
PHST- 2007/03/14 09:00 [entrez]
AID - 4W564520053X4083 [pii]
AID - 10.1532/LH96.06030 [doi]
PST - ppublish
SO  - Lab Hematol. 2007;13(1):30-3. doi: 10.1532/LH96.06030.